vs
ABVC BIOPHARMA, INC.（ABVC）与Pineapple Financial Inc.（PAPL）财务数据对比。点击上方公司名可切换其他公司
ABVC BIOPHARMA, INC.的季度营收约是Pineapple Financial Inc.的1.1倍（$796.0K vs $707.3K），ABVC BIOPHARMA, INC.净利率更高（-256.6% vs -2756.2%，领先2499.6%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs -4.8%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs -2.0%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
ABVC vs PAPL — 直观对比
营收规模更大
ABVC
是对方的1.1倍
$707.3K
营收增速更快
ABVC
高出109.3%
-4.8%
净利率更高
ABVC
高出2499.6%
-2756.2%
两年增速更快
ABVC
近两年复合增速
-2.0%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $707.3K |
| 净利润 | $-2.0M | $-19.5M |
| 毛利率 | 100.0% | 48.9% |
| 营业利润率 | -246.8% | -2518.8% |
| 净利率 | -256.6% | -2756.2% |
| 营收同比 | 104.5% | -4.8% |
| 净利润同比 | -417.4% | -3174.1% |
| 每股收益（稀释后） | $-0.09 | $-1.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCPAPL
| Q1 26 | — | $707.3K | ||
| Q4 25 | — | $721.7K | ||
| Q3 25 | $796.0K | $730.5K | ||
| Q2 25 | — | $746.9K | ||
| Q1 25 | — | $743.3K | ||
| Q4 24 | $2.0K | $766.1K | ||
| Q3 24 | $389.3K | $598.3K | ||
| Q2 24 | $117.1K | $736.4K |
净利润ABVCPAPL
| Q1 26 | — | $-19.5M | ||
| Q4 25 | — | $-6.4M | ||
| Q3 25 | $-2.0M | $-1.8M | ||
| Q2 25 | — | $-557.7K | ||
| Q1 25 | — | $-595.4K | ||
| Q4 24 | — | $-656.9K | ||
| Q3 24 | $-394.8K | $-1.7M | ||
| Q2 24 | $-942.3K | $-848.6K |
毛利率ABVCPAPL
| Q1 26 | — | 48.9% | ||
| Q4 25 | — | 49.6% | ||
| Q3 25 | 100.0% | 27.8% | ||
| Q2 25 | — | 67.6% | ||
| Q1 25 | — | 43.4% | ||
| Q4 24 | 100.0% | 45.9% | ||
| Q3 24 | 99.9% | 43.2% | ||
| Q2 24 | 99.8% | 44.2% |
营业利润率ABVCPAPL
| Q1 26 | — | -2518.8% | ||
| Q4 25 | — | -909.1% | ||
| Q3 25 | -246.8% | -131.3% | ||
| Q2 25 | — | -93.3% | ||
| Q1 25 | — | -80.6% | ||
| Q4 24 | — | -90.5% | ||
| Q3 24 | -77.7% | -232.8% | ||
| Q2 24 | -734.2% | -121.7% |
净利率ABVCPAPL
| Q1 26 | — | -2756.2% | ||
| Q4 25 | — | -891.6% | ||
| Q3 25 | -256.6% | -250.3% | ||
| Q2 25 | — | -74.7% | ||
| Q1 25 | — | -80.1% | ||
| Q4 24 | — | -85.7% | ||
| Q3 24 | -101.4% | -283.9% | ||
| Q2 24 | -804.4% | -115.2% |
每股收益（稀释后）ABVCPAPL
| Q1 26 | — | $-1.21 | ||
| Q4 25 | — | $-4.79 | ||
| Q3 25 | $-0.09 | $-0.93 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $-1.73 | ||
| Q4 24 | — | $-2.60 | ||
| Q3 24 | $-0.03 | $-11.10 | ||
| Q2 24 | $-0.08 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $27.1M |
| 总资产 | $21.2M | $48.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABVCPAPL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $257.2K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $313.1K | — | ||
| Q3 24 | $208.2K | — | ||
| Q2 24 | $200.0K | — |
股东权益ABVCPAPL
| Q1 26 | — | $27.1M | ||
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $12.1M | $906.7K | ||
| Q2 25 | — | $842.6K | ||
| Q1 25 | — | $739.7K | ||
| Q4 24 | $1.2M | $1.3M | ||
| Q3 24 | $1.6M | $1.3M | ||
| Q2 24 | $1.8M | $2.0M |
总资产ABVCPAPL
| Q1 26 | — | $48.9M | ||
| Q4 25 | — | $10.6M | ||
| Q3 25 | $21.2M | $5.4M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | — | $4.0M | ||
| Q4 24 | $7.5M | $4.1M | ||
| Q3 24 | $7.8M | $4.1M | ||
| Q2 24 | $8.0M | $4.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $-3.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-3.3M |
| 自由现金流率自由现金流/营收 | — | -462.7% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABVCPAPL
| Q1 26 | — | $-3.3M | ||
| Q4 25 | — | $-489.7K | ||
| Q3 25 | $-964.7K | $-507.6K | ||
| Q2 25 | — | $397.0K | ||
| Q1 25 | — | $-172.6K | ||
| Q4 24 | $-1.8M | $-663.6K | ||
| Q3 24 | $60.2K | $-264.7K | ||
| Q2 24 | $-211.4K | $123.0K |
自由现金流ABVCPAPL
| Q1 26 | — | $-3.3M | ||
| Q4 25 | — | $-491.7K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-264.7K | ||
| Q2 24 | — | $122.7K |
自由现金流率ABVCPAPL
| Q1 26 | — | -462.7% | ||
| Q4 25 | — | -68.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -44.2% | ||
| Q2 24 | — | 16.7% |
资本支出强度ABVCPAPL
| Q1 26 | — | 0.0% | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
